During their October 19-20, 2022, meeting the Advisory Committee on Immunization Practices (ACIP) further expanded upon their pneumococcal vaccination recommendation for adults who have previously received a Prevnar 13® and/or Pneumovax 23® vaccine.
The ACIP voted to recommend the following for people who previously received PCV13, summarized in the table below by Immunize.org:
CPP Member Pricing
If your practice is not yet linked to CPP through the Pfizer portal, contact the CPP office for detailed instructions for how to enroll in this discount opportunity.